TP53 and neoplasm: Accordingly, with the G1/S checkpoint compromised, the SRA737 inhibition of CHK1 delivers a state of synthetic lethality in P53 deficient cells, leading to irreparable levels of DNA damage, mitotic catastrophe and subsequent tumour cell death.